U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C12H14N2
Molecular Weight 186.253
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TETRAHYDROHARMANE

SMILES

CC1NCCC2=C1NC3=C2C=CC=C3

InChI

InChIKey=LPIJOZBIVDCQTE-UHFFFAOYSA-N
InChI=1S/C12H14N2/c1-8-12-10(6-7-13-8)9-4-2-3-5-11(9)14-12/h2-5,8,13-14H,6-7H2,1H3

HIDE SMILES / InChI
Molecular Formula C12H14N2
Molecular Weight 186.253
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
Inhibitor
8297
PubMed

PubMed

TitleDatePubMed
Formation of tetrahydroharman (1-methyl-1,2,3,4-tetrahydro-beta-carboline) by Helicobacter pylori in the presence of ethanol and tryptamine.
1996
Antimalarial activity of extracts and alkaloids isolated from six plants used in traditional medicine in Mali and Sao Tome.
2002 Nov
Substance Class Chemical
Created
by admin
on Sat Dec 16 12:49:27 GMT 2023
Edited
by admin
on Sat Dec 16 12:49:27 GMT 2023
Record UNII
W6CLK26X7V
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TETRAHYDROHARMANE
Common Name English
2,3,4,9-TETRAHYDRO-1-METHYL-1H-PYRIDO(3,4-B)INDOLE
Systematic Name English
(±)-TETRAHYDROHARMAN
Common Name English
1-METHYL-2,3,4,9-TETRAHYDRO-1H-PYRIDO(3,4-B)INDOLE
Systematic Name English
(±)-TETRAHYDROHARMANE
Common Name English
TETRAHYDROHARMAN
Common Name English
CALLIGONINE
Common Name English
ELEAGNINE
Common Name English
1H-PYRIDO(3,4-B)INDOLE, 2,3,4,9-TETRAHYDRO-1-METHYL-
Systematic Name English
(±)-1-METHYL-1,2,3,4-TETRAHYDRO-.BETA.-CARBOLINE
Common Name English
1,2,3,4-TETRAHYDROHARMANE
Common Name English
1-METHYL-1,2,3,4-TETRAHYDRO-.BETA.-CARBOLINE
Common Name English
NSC-92525
Code English
Code System Code Type Description
EPA CompTox
DTXSID901027440
Created by admin on Sat Dec 16 12:49:27 GMT 2023 , Edited by admin on Sat Dec 16 12:49:27 GMT 2023
PRIMARY
FDA UNII
W6CLK26X7V
Created by admin on Sat Dec 16 12:49:27 GMT 2023 , Edited by admin on Sat Dec 16 12:49:27 GMT 2023
PRIMARY
CAS
2506-10-7
Created by admin on Sat Dec 16 12:49:27 GMT 2023 , Edited by admin on Sat Dec 16 12:49:27 GMT 2023
PRIMARY
ECHA (EC/EINECS)
219-711-4
Created by admin on Sat Dec 16 12:49:27 GMT 2023 , Edited by admin on Sat Dec 16 12:49:27 GMT 2023
PRIMARY
NSC
92525
Created by admin on Sat Dec 16 12:49:27 GMT 2023 , Edited by admin on Sat Dec 16 12:49:27 GMT 2023
PRIMARY
PUBCHEM
91522
Created by admin on Sat Dec 16 12:49:27 GMT 2023 , Edited by admin on Sat Dec 16 12:49:27 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966